Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | KDM4A | O75164 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5237590 | 1.00 | CYP1A2 (0.45) | CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL7474494 | 1.00 | CYP1A2 (0.45) | CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL7476910 | 0.84 | KDM4E (0.41) | CYP1A2CYP2C9CYP2C19CYP3A4KDM4E | |
| SCHEMBL7473946 | 0.81 | TRPC5 (0.44) | CYP1A2CYP2C9CYP2C19KDM4EHSD17B10 | |
| SCHEMBL7477781 | 0.76 | KDM4E (0.47) | CYP1A2CYP2C9CYP2C19KDM4EHSD17B10 | |
| SCHEMBL9739218 | 0.75 | ALDH1A1 (0.43) | CYP1A2CYP2C9CYP2C19KDM4EHSD17B10 | |
| SCHEMBL7474836 | 0.75 | KDM4E (0.43) | CYP1A2CYP2C9CYP2C19KDM4EHSD17B10 | |
| SCHEMBL7475545 | 0.74 | KDM4E (0.42) | CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL7478981 | 0.74 | KDM4E (0.42) | CYP1A2CYP2C9CYP2C19KDM4EHSD17B10 | |
| SCHEMBL7474802 | 0.74 | KDM4E (0.43) | CYP1A2CYP2C9CYP2C19KDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1254907-B1 | PYRROLOPYRIDAZINE COMPOUND | SANKYO CO (JP) | 2007-05-09 | — | — | EP | disclosed |
| US-6734181-B2 | GASTRIC ACID SECRETORY INHIBITION ACTIVITY, GASTRIC MUCOUS MEMBRANE PROTECTION ACTIVITY; TREATMENT OF ULCERS AND HELICOBACTER PYLORI INFECIONS | SANKYO COMPANY, LIMITED (JP) | 2004-05-11 | — | — | US | disclosed |
| US-20040014762-A1 | Pyrrolopyridazine compounds | SANKYO COMPANY, LIMITED (JP) | 2004-01-22 | — | — | US | disclosed |
| US-6670360-B2 | Antiulcer, antibacterial activity against Helicobacter pylori | SANKYO COMPANY, LIMITED (JP) | 2003-12-30 | — | — | US | disclosed |
| EP-1186607-B1 | OPTICALLY ACTIVE PYRROLOPYRIDAZINE COMPOUNDS | SANKYO CO (JP) | 2003-05-21 | — | — | EP | disclosed |
| EP-1254907-A1 | PYRROLOPYRIDAZINE COMPOUND | Sankyo Company, Limited (JP) | 2002-11-06 | — | — | EP | disclosed |
| US-20020156079-A1 | Optically active pyrrolopyridazine derivatives | SANKYO COMPANY, LIMITED (JP) | 2002-10-24 | — | — | US | disclosed |
| EP-1186607-A1 | OPTICALLY ACTIVE PYRROLOPYRIDAZINE COMPOUNDS | Sankyo Company, Limited (JP) | 2002-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156079-A1 | Optically active pyrrolopyridazine derivatives | GIPR, HRH2, PGA5 | CYP1A2 858/4885CYP2C9 1260/4885CYP2C19 259/4885 |
| US-20040014762-A1 | Pyrrolopyridazine compounds | HRH2, ADH1C, GIPR | CYP1A2 1171/4885CYP2C9 821/4885CYP2C19 357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.